These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 4593264

  • 1. Preliminary results of a controlled therapeutic trail administering INH-RMP once-weekly, after--or without--an initial period of continuous treatment.
    Eule H, Kärnbach E, Kaluza P, Herrmann H.
    Scand J Respir Dis Suppl; 1973; 84():153-9. PubMed ID: 4593264
    [No Abstract] [Full Text] [Related]

  • 2. Immunological and haematological investigations on patients with adverse reactions during treatment with RMP plus INH once-weekly.
    Herrmann H, Eule H.
    Scand J Respir Dis Suppl; 1973; 84():87-93. PubMed ID: 4593270
    [No Abstract] [Full Text] [Related]

  • 3. Controlled clinical evaluation of three intermittent regimens employing low-dosage schedules of rifampicin in original treatment of pulmonary tuberculosis. Preliminary data on effectiveness and side effects.
    Nitti V.
    Scand J Respir Dis Suppl; 1973; 84():180-5. PubMed ID: 4593266
    [No Abstract] [Full Text] [Related]

  • 4. Side effects observed during intermittent rifampicin therapy.
    Stradling P.
    Scand J Respir Dis Suppl; 1973; 84():129-31. PubMed ID: 4522066
    [No Abstract] [Full Text] [Related]

  • 5. Side effects during intermittent rifampicin and ethambutol treatment. A preliminary report.
    Guerra Sanz FJ.
    Scand J Respir Dis Suppl; 1973; 84():160-5. PubMed ID: 4522071
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Preliminary results of a therapeutic trial concerning the administration of isoniazid + rifampicin once a week, immediately or after an initial period of continuous treatment].
    Eule H.
    Bull Int Union Tuberc; 1973 Jun; 48(0):117-24. PubMed ID: 4602466
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Tuberculosis treated with rifampicin, ethambutol and isoniazid: Danish tuberculosis trial 1972-1974.
    Engbaek HC, Heckscher T, Højgaard C, Larsen SO, Rasmussen KN, Vergmann B.
    Eur J Respir Dis; 1982 Mar; 63(2):84-93. PubMed ID: 7040100
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The intermittent chemotherapy of tuberculosis with rifampicin regimens on ambulatory basis.
    Anastasatu C, Bungeteanu G, Sibila S.
    Scand J Respir Dis Suppl; 1973 Mar; 84():136-9. PubMed ID: 4522068
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Is the combination of INH and RFP always bactericidal? An observation in programme condition--report of the B series of 20th Controlled Trial of Chemotherapy (author's transl)].
    Kekkaku; 1980 Apr; 55(4):207-14. PubMed ID: 6993746
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Therapeutic effects and side effects of rifampicin administered daily or twice-weekly.
    Gomi J, Aoyagi T.
    Scand J Respir Dis Suppl; 1973 Apr; 84():145-52. PubMed ID: 4522070
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.